{{Infobox company
| name             = Incyte Corporation
| logo             =
| caption          = 
| type             = [[上市公司|上市公司]]
| traded_as        = {{NASDAQ|INCY}}<br>[[NASDAQ-100|NASDAQ-100 Component]]<br>[[S&P_500|S&P 500 Component]]
| fate             = 
| predecessor      = 
| successor        = 
| foundation       = {{Start date|1991}}
| founder          = 
| defunct          = <!-- {{End date|YYYY|MM|DD}} -->
| location_city    = 特拉华州[[威尔明顿_(特拉华州)|威尔明顿]]
| location_country = 美国
| locations        = 
| area_served      = 
| key_people       = Hervé Hoppenot（总裁兼CEO）
| industry         = [[制药|制药]]
| products         = 
| services         = 
| revenue          = {{increase}} $US 15亿（2017）
| operating_income = 
| net_income       ={{increase}} $US $3亿（2017）
| assets           = {{increase}} $US 15.04亿（2017）
| equity           = {{Increase}} $US 16.32亿（2017）
| owner            = 
| num_employees    = ~700<ref name="top"/>
| parent           = 
| divisions        = 
| subsid           = 
| homepage         = {{URL|http://www.incyte.com|www.incyte.com}}
| footnotes        = <ref name=2011_10K>{{Citation |author=Incyte Corporation |publication-date=February 22, 2012 |year=2012 |title=Form 10-K |type=[[SEC_filing|SEC filing]] |id=Commission File Number: 0-27488 |publisher=Incyte Corporation |url=http://investor.incyte.com/phoenix.zhtml?c=69764&p=IROL-secToc&TOC=aHR0cDovL2lyLmludC53ZXN0bGF3YnVzaW5lc3MuY29tL2RvY3VtZW50L3YxLzAwMDEwNDc0NjktMTItMDAxMjk1L3RvYy9wYWdl&ListAll=1&sXBRL=1 |accessdate=May 6, 2012 |archive-url=https://archive.is/20130126183519/http://investor.incyte.com/phoenix.zhtml?c=69764&p=IROL-secToc&TOC=aHR0cDovL2lyLmludC53ZXN0bGF3YnVzaW5lc3MuY29tL2RvY3VtZW50L3YxLzAwMDEwNDc0NjktMTItMDAxMjk1L3RvYy9wYWdl&ListAll=1&sXBRL=1 |archive-date=2013-01-26 |dead-url=yes }}</ref>
| intl             = 
}}

'''因赛特'''（Incyte, Corp），又译'''英赛德'''，是一家美国制药公司，1991年成立于加州[[帕罗奥图|帕罗奥图]]，1993年上市<ref name="top">{{cite web|url=http://www.delawareonline.com/story/money/business/2015/03/02/incyte-wins-delaware-bio-company-year-honor/24282977/|title= Incyte is Delaware Bio Company of the Year, again| date= 2 Mar 2015| author= Scott Goss| website=delawareonline.com|accessdate= 2 Mar 2015}}</ref>。

该公司生产有治疗骨髓纤维化的[[Jakafi|Jakafi]]<ref name=natoli2012>{{Citation |last=Natoli |first=Cori Anne |publication-date=May 5, 2012 |title=Incyte looks to ride on drug's success |newspaper=[[The_News_Journal|The News Journal]] |url=http://www.delawareonline.com/article/20120506/BUSINESS/205060304/Incyte-looks-to-ride-on-drug-s-success |accessdate=May 6, 2012 }}</ref>。此外和还和[[礼来制药|礼来制药]]开发有治疗类风湿性关节炎的[[baricitinib|baricitinib]]<ref>{{cite web| url=https://www.insideindianabusiness.com/newsitem.asp?ID=68416| title=Lilly, Incyte Treatment Shows Positive Results| date=9 Dec 2014| accessdate=2 Mar 2015| website=www.insideindianabusiness.com}}{{dead link|date=November 2017 |bot=InternetArchiveBot |fix-attempted=yes }}</ref><ref name="urlwww.ama-assn.org">{{cite web | url = http://www.ama-assn.org/resources/doc/usan/baricitinib.pdf | title = Baricitinib | format = pdf | work = Statement on a nonproprietary name adopted by the USAN council | publisher = American Medical Association }}</ref>，但此药物因安全性问题在2017年4月被[[FDA|FDA]]禁止销售<ref>{{cite news|url=http://www.businessinsider.com/fda-rejects-lilly-and-incytes-baricitinib-2017-4|title=The FDA shot down a new rheumatoid arthritis drug — and the companies that make the drug are tumbling|publisher=Business Insider|author=Ramsey, L|date=17 April 2017}}</ref><ref>{{cite news|url=https://www.wsj.com/articles/surprise-fda-rejection-will-sting-this-biotech-1492185721|title=Surprise FDA Rejection Will Sting This Biotech|publisher=The Wall Street Journal|author=Grant, Ch|date=14 April 2017}}</ref>。

==参考文献==
{{reflist}}

== 外部连接 ==
{{Finance links
| name = Incyte
| symbol = INCY
| sec_cik = INCY
| yahoo = INCY
| google = INCY
}}

{{NASDAQ-100}}

[[Category:美国制药公司|Category:美国制药公司]]
[[Category:1991年成立的公司|Category:1991年成立的公司]]